Chemical Formula: C18H25N3O6

Chemical Formula C18H25N3O6

Found 36 metabolite its formula value is C18H25N3O6

   

oryzamutaic acid H

oryzamutaic acid H

C18H25N3O6 (379.1743)


   
   

SCHEMBL17305518

SCHEMBL17305518

C18H25N3O6 (379.1743)


   
   
   
   
   
   
   
   
   
   
   
   

6-CHLORO-2-HEXANONE

6-CHLORO-2-HEXANONE

C18H25N3O6 (379.1743)


   

Z-Ile-Gly-Gly-OH

Z-Ile-Gly-Gly-OH

C18H25N3O6 (379.1743)


   

z-gly-gly-leu-oh

z-gly-gly-leu-oh

C18H25N3O6 (379.1743)


   

Frovatriptan

Frovatriptan Succinate monohydrate

C18H25N3O6 (379.1743)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist Frovatriptan succinate hydrate ((R)-Frovatriptan succinate hydrate) is a potent, high affinity, selective and orally active 5-HT1B (pK50 of 8.2) and 5-HT1D receptor agonist. Frovatriptan succinate hydrate exhibits >10-fold selectivity for 5-HT1B and 5-HT1D over 5-HT1A, 5-HT1F, and 5-HT7 and >1000-fold selectivity over other 5-HT, dopamine, histamine H1, and α1-adrenoceptor. Frovatriptan succinate hydrate has the potential for migraine research[1][2].

   

Phe-Val-Asp

Phe-Val-Asp

C18H25N3O6 (379.1743)


A tripeptide composed of L-phenylalanine, L-valine, and L-aspartic acid joined by peptide linkages.

   

L-threonyl-L-prolyl-L-tyrosine

L-threonyl-L-prolyl-L-tyrosine

C18H25N3O6 (379.1743)


   
   
   
   
   
   
   
   
   
   
   

Thr-Pro-Tyr

Thr-Pro-Tyr

C18H25N3O6 (379.1743)


A tripeptide composed of L-threonine, L-proline, and L-tyrosine joined by peptide linkages.

   

3-({1-[(5-aminopentyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl}-c-hydroxycarbonimidoyl)oxirane-2-carboxylic acid

3-({1-[(5-aminopentyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl}-c-hydroxycarbonimidoyl)oxirane-2-carboxylic acid

C18H25N3O6 (379.1743)


   

(2s,3s)-3-{[(1s)-1-[(5-aminopentyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid

(2s,3s)-3-{[(1s)-1-[(5-aminopentyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid

C18H25N3O6 (379.1743)


   

5-(3-amino-3-carboxypropyl)-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3,8-dicarboxylic acid

5-(3-amino-3-carboxypropyl)-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3,8-dicarboxylic acid

C18H25N3O6 (379.1743)


   

(3s,8s,11as,11bs)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3,8-dicarboxylic acid

(3s,8s,11as,11bs)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3,8-dicarboxylic acid

C18H25N3O6 (379.1743)